Trinity Health Grand Rapids is First in West Michigan to Treat Heart Failure Patients Using Breakthrough CCM Therapy
May 8, 2023Categories: Heart Health
Innovative minimally-invasive therapy is proven to help people with heart failure
GRAND RAPIDS, Mich. (May 9, 2023) – Trinity Health Grand Rapids today announced it is among the first hospitals in the United States and the only hospital in West Michigan to use CCMTM therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure. Heart failure is a progressive condition with debilitating symptoms that can severely limit the quality of life for heart failure patients.
CCM therapy, also known as cardiac contractility modulation, is a new, FDA-approved heart failure treatment proven to improve quality of life for patients that are no longer adequately responding to medications to manage symptoms or slow the progression of heart failure.1 The innovative therapy is intended to improve the contraction of the heart, allowing more oxygen-rich blood to reach the body, by delivering precisely timed electrical pulses from a device that is implanted under the skin. CCM Therapy can be used in conjunction with medications and other heart failure therapies.
Cardiologist H. Paul Singh, MD, MBA, FACC, treated the first West Michigan patient with CCM therapy at Trinity Health Grand Rapids in May of 2023. Trinity Health Grand Rapids is a member of the Cardiovascular Network of West Michigan.
“CCM therapy is a breakthrough therapy option for heart failure patients that is intended to help them feel better, so they can start doing the things they love again,” said Dr. Singh. “Medications are not always enough to help slow the progression of heart failure and improve the quality of life for these patients. CCM therapy is a breakthrough treatment option that brings hope to this patient population by improving the often-debilitating symptoms of heart failure.”
Heart failure, a condition in which the heart slowly weakens and is not able to adequately supply oxygen-rich blood, affects an estimated 6.5 million Americans and nearly 26 million people worldwide.2 By 2030, it is expected to affect 8 million Americans.3
Heart failure patients experience debilitating symptoms, including breathlessness, fatigue, confusion and swelling in the legs that make everyday activities challenging and significantly diminish their quality of life. Today, most heart failure patients are prescribed medications intended to slow the progression of the disease and manage their symptoms. As the condition progresses, these treatments lose their effectiveness and the quality of life for heart failure patients continues to decline.
CCM therapy may be an appropriate option for up to 70-percent of NYHA Class III (a classification of heart symptoms) heart failure patients who continue to experience symptoms despite taking the optimal heart failure medications for their condition.1
Talk with your cardiologist to determine is CCM therapy is right for you. For more information, visit www.TrinityHealthMichigan.org/CCM.
CCM therapy was developed by Impulse Dynamics, based in Mount Laurel, NJ. Visit www.Impulse-Dynamics.com to learn more about the company.
About Trinity Health Michigan
Trinity Health Michigan is a leading health care provider and one of the state’s largest employers. With more than 24,000 full-time employees serving 29 counties, Trinity Health Michigan operates nine hospitals located in Ann Arbor, Chelsea, Grand Haven, Grand Rapids, Howell, Livonia, Muskegon, Pontiac and Shelby, and two medical groups. The health system has 2,314 beds and 5,446 physicians and advanced practice providers. With operating revenues of $4.16 billion, Trinity Health Michigan returns $184 million back to their local communities each year. Together with numerous ambulatory care locations, home health and hospice agencies and 23 senior living communities owned and/or operated by Trinity Health, Trinity Health Michigan provides the full continuum of care for Michigan residents. Trinity Health Michigan is a member of Trinity Health, one of the largest Catholic health care systems in the country serving more than 30 million people across 22 states. www.trinityhealthmichigan.org
References
1 Abraham WT, Kuck KH, Goldsmith RL, et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Failure. 6(10), 874-883 (2018).
2 Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr; 3(1): 7–11.
3 Benjamin E.J., Blaha M.J., Chiuve S.E., et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 2017; 135: pp. e146-e603